James E. Flynn 13D and 13G filings for Puma Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-11 4:21 pm Sale | 2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI | James E. Flynn | 0 0.000% | -3,959,741![]() (Position Closed) | Filing |
2021-02-12 12:30 pm Purchase | 2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI | James E. Flynn | 3,959,741 9.960% | 1,681,588![]() (+73.81%) | Filing |
2020-08-10 2:52 pm Purchase | 2020-08-07 | 13G | Puma Biotechnology, Inc. PBYI | James E. Flynn | 2,278,153 5.740% | 2,278,153![]() (New Position) | Filing |